Press releases Image FR Corporate / 06.12.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Corporate / 05.12.2024 New generation steps up to continue IBA’s entrepreneurial ownership Read more New generation steps up to continue IBA’s entrepreneurial ownership
Press releases Image EN FR Corporate / 21.11.2024 IBA Business Update – Third Quarter 2024 Read more IBA Business Update – Third Quarter 2024
Press releases Image EN FR Industrial Solutions / 20.11.2024 IBA signs contract with BENEBION for the installation of a Rhodotron® to equip a cutting-edge irradiation facility in Mexico Read more IBA signs contract with BENEBION for the installation of a Rhodotron® to equip a cutting-edge irradiation facility in Mexico
Press releases Image EN FR RadioPharma Solutions / 18.11.2024 Almathera selects IBA to equip Kazakhstan’s first private radiopharmacy and theranostics complex with Cyclone® KIUBE 300 Read more Almathera selects IBA to equip Kazakhstan’s first private radiopharmacy and theranostics complex with Cyclone® KIUBE 300
Press releases Image EN FR Industrial Solutions / 06.11.2024 IBA signs contract with SteriLab for E-beam sterilization solution in the Dominican Republic Read more IBA signs contract with SteriLab for E-beam sterilization solution in the Dominican Republic
Press releases Image EN FR RadioPharma Solutions / 29.10.2024 IBA partners with Jubilant Radiopharma, selling five Cyclone® KIUBE to support their PET radioisotope production across the US Read more IBA partners with Jubilant Radiopharma, selling five Cyclone® KIUBE to support their PET radioisotope production across the US
Press releases Image EN FR RadioPharma Solutions / 03.10.2024 IBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create complete Astatine-211 value chain Read more IBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create complete Astatine-211 value chain
Press releases Image EN FR Corporate / 11.09.2024 IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production Read more IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production
Reports Image EN FR Corporate / 29.08.2024 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2024 Read more UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2024
Presentations Image EN Corporate / 29.08.2024 IBA Half Year 2024 Results Presentation Read more IBA Half Year 2024 Results Presentation
Press releases Image EN FR Corporate / 29.08.2024 IBA Reports Half Year 2024 Results Read more IBA Reports Half Year 2024 Results
Press releases Image FR EN Proton Therapy / 27.08.2024 IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions Read more IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions
Legal Image FR EN Corporate / 01.08.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image FR EN Corporate / 01.08.2024 IBA Notice of Half Year 2024 Results and Conference Call Read more IBA Notice of Half Year 2024 Results and Conference Call
Legal Image FR Corporate / 12.06.2024 Voting results AGM 12 June 2024 Read more Voting results AGM 12 June 2024
Brochures Image EN FR Corporate / 03.06.2024 IBA Corporate Brochure 2024 Read more IBA Corporate Brochure 2024
Press releases Image EN FR Corporate / 23.05.2024 IBA Business Update – First Quarter 2024 Read more IBA Business Update – First Quarter 2024
Legal Image EN FR Corporate / 10.05.2024 NOTICE OF THE ORDINARY GENERAL MEETING 2024 OF IBA SA - WEDNESDAY, JUNE 12, 2024 Read more NOTICE OF THE ORDINARY GENERAL MEETING 2024 OF IBA SA - WEDNESDAY, JUNE 12, 2024
Legal Image FR Corporate / 10.05.2024 THE ORDINARY GENERAL MEETING 2024 OF IBA SA - WEDNESDAY, JUNE 12, 2024 - PROXY VOTE Read more THE ORDINARY GENERAL MEETING 2024 OF IBA SA - WEDNESDAY, JUNE 12, 2024 - PROXY VOTE
